{"ticker": {"uuid": "97b34de1-5f6e-4bce-8d9a-a119ccb6fa3e", "symbol": "300026", "name": "Tianjin Chase Sun Pharmaceutical Co.,Ltd", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Chase Sun Pharmaceutical Terminates 7.6 Million Yuan Anti-HCV Drug R&D; 16-Year Project Falters in Preclinical Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE02WGVFNmt1UlAwVUxJM3BMRWotdzlOd2xwM29xS2RnWi03ZWQ3cnZPTklxRWstWDZmRkl5QzM3b0hyUE90M3RQZkVBUlBjZzFWQnNNeDZ1VUMyejF4OHo5aE9yMU1JNWthYTJQMDZPdjJ6YnpPMGc?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-07-09T05:55:00+00:00", "published_display": "09 Jul 2026 05:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dingxi eyes TCM growth through Beijing-Tianjin-Hebei cooperation", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1OY2NaRFdIZnAxWmV3SUJocUg5UWRMem11SDVUb2xHZXAta2k1bG91aWcxdDE3ajlqYnVXbkFEaFhFZFN4YnBVYnU5cE1kSTlpaEZTWS1ncWVqY3JMaktnRUY1TGRKejl5M2VEVEFXMWNVWjR3VWVGWkd6WDNSdw?oc=5", "source_name": "China Daily", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Chase Sun Pharmaceutical Terminates 7.6 Million Yuan Anti-HCV Drug R&D; 16-Year Project Falters in Preclinical Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE02WGVFNmt1UlAwVUxJM3BMRWotdzlOd2xwM29xS2RnWi03ZWQ3cnZPTklxRWstWDZmRkl5QzM3b0hyUE90M3RQZkVBUlBjZzFWQnNNeDZ1VUMyejF4OHo5aE9yMU1JNWthYTJQMDZPdjJ6YnpPMGc?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-07-09T05:55:00+00:00", "published_display": "09 Jul 2026 05:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dingxi eyes TCM growth through Beijing-Tianjin-Hebei cooperation", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1OY2NaRFdIZnAxWmV3SUJocUg5UWRMem11SDVUb2xHZXAta2k1bG91aWcxdDE3ajlqYnVXbkFEaFhFZFN4YnBVYnU5cE1kSTlpaEZTWS1ncWVqY3JMaktnRUY1TGRKejl5M2VEVEFXMWNVWjR3VWVGWkd6WDNSdw?oc=5", "source_name": "China Daily", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 43, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 58, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3.28, "latest_week": "2026-07-17", "one_week_move": 3.8, "four_week_move": 8.9, "twelve_week_move": -2.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.596405, "market_dynamics_buy_signal": false, "relative_strength": -10.671581, "fair_value_gap": -13.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.8545, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.8% over one week, +8.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.biggo.com", "count": 1}, {"label": "China Daily", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.8% over one week, +8.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Chase Sun Pharmaceutical Terminates 7.6 Million Yuan Anti-HCV Drug R&D; 16-Year Project Falters in Preclinical Stage"}], "updated_at": "2026-07-21T21:29:34.025285+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}